Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITIONS AND METHODS FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Document Type and Number:
WIPO Patent Application WO/2021/142347
Kind Code:
A1
Abstract:
The present disclosure is in the field of pharmaceutical compositions suitable for the treatment of NAFLD or NASH in mammals. The disclosure provides novel compositions comprising non-pathogenic fecal microbes for treating non-alcoholic steatohepatitis (NASH) and related diseases. The disclosure also provides methods for treating a subject with the compositions disclosed herein.

Inventors:
SMITH MARK (US)
KASSAM ZAIN (US)
Application Number:
PCT/US2021/012812
Publication Date:
July 15, 2021
Filing Date:
January 08, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
FINCH THERAPEUTICS HOLDINGS LLC (US)
International Classes:
A61K35/74; A61P1/16
Domestic Patent References:
WO2018140931A12018-08-02
WO2016183577A12016-11-17
WO2012122478A12012-09-13
WO2012016287A22012-02-09
WO2012122478A12012-09-13
WO2012016287A22012-02-09
WO2014078911A12014-05-30
WO2011033310A12011-03-24
WO2007122374A22007-11-01
WO2008135090A12008-11-13
WO2014152484A12014-09-25
Foreign References:
US7541091B22009-06-02
US20110045222A12011-02-24
US20110008554A12011-01-13
US20100255231A12010-10-07
US4394377A1983-07-19
US7482152B22009-01-27
US20160317583A12016-11-03
US7799328B22010-09-21
US8535713B22013-09-17
US8911777B22014-12-16
US20120141585A12012-06-07
US20120141531A12012-06-07
US20060001896A12006-01-05
US20070292523A12007-12-20
US20080020018A12008-01-24
US20080113031A12008-05-15
US20100203120A12010-08-12
US20100255087A12010-10-07
US20100297221A12010-11-25
US20110052645A12011-03-03
US20130243873A12013-09-19
US20130330411A12013-12-12
US20140017313A12014-01-16
US20140234418A12014-08-21
US4196564A1980-04-08
US4196565A1980-04-08
US4247006A1981-01-27
US4250997A1981-02-17
US4268265A1981-05-19
US5317849A1994-06-07
US6572892B12003-06-03
US7712634B22010-05-11
US8074835B22011-12-13
US8398912B22013-03-19
US8440224B22013-05-14
US8557294B22013-10-15
US8646591B22014-02-11
US8739812B22014-06-03
US8810259B22014-08-19
US8852631B22014-10-07
US8911788B22014-12-16
US20140302132A12014-10-09
US20140227357A12014-08-14
US20140088202A12014-03-27
US20130287842A12013-10-31
US20130295188A12013-11-07
US20130307962A12013-11-21
US20130184290A12013-07-18
US4537776A1985-08-27
US20140147417A12014-05-29
Other References:
EBRAHIMZADEH LEYLABADLO HAMED ET AL: "Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies", EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, SPRINGER, WIESBADEN, DE, vol. 39, no. 4, 11 December 2019 (2019-12-11), pages 613 - 627, XP037070995, ISSN: 0934-9723, [retrieved on 20191211], DOI: 10.1007/S10096-019-03746-1
ZHOU DA ET AL: "Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota", SCIENTIFIC REPORTS, vol. 7, no. 1, 8 May 2017 (2017-05-08), pages 1 - 11, XP055777414, Retrieved from the Internet DOI: 10.1038/s41598-017-01751-y
CHU, N. ET AL.: "Profiling living bacteria informs preparation of fecal microbiota transplantations", PLOS ONE, vol. 12, no. 1, 2017, pages 1 - 16, XP055619403, DOI: 10.1371/journal.pone.0170922
GEVERS ET AL.: "The treatment-naive microbiomes in new-onset Crohn's disease", CELL HOST & MICROBE, vol. 15, no. 3, 2014, pages 382 - 92
GEVERS ET AL., CELL HOST & MICROBE, vol. 15, no. 3, 2014, pages 382 - 92
CHU ET AL., PLOS ONE, vol. 12, no. 1, 2017, pages 1 - 16
STOCKS, CYTOMETRY A., vol. 61, no. 2, October 2004 (2004-10-01), pages 189 - 95
CANGELOSIMESCHEKE, APPL ENVIRON MICROBIOL, vol. 80, no. 19, October 2014 (2014-10-01), pages 5884 - 5891
SHANNONWEAVER: "The mathematical theory of communication", 1949, THE UNIVERSITY OF ILLINOIS PRESS, pages: 117
OTT ET AL., GASTROENTEROLOGY, vol. 152, 2017, pages 799 - 911
LI ET AL., AAPS PHARMSCITECH, vol. 3, no. 4, 2002, pages 1 - 9
CHALASANI ET AL., HEPATOLOGY, vol. 1, no. 67, 2018, pages 328 - 357
CHALASANI, NAMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASESAMERICAN COLLEGE OF GASTROENTEROLOGYAMERICAN GASTROENTEROLOGICAL A: "The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline", HEPATOLOGY, vol. 55, no. 6, 2012, pages 2005 - 2023, XP055624306, DOI: 10.1002/hep.25762
REEDER, S.SIRLIN, C., MAGN RESON IMAGING CLIN N AM, vol. 18, no. 3, 2010, pages 337 - 357
KOLODZIEJCZYK, A. ET AL., EMBO MOL MED, vol. 11, no. 2, 2019, pages 1 - 13
MA, H. ET AL., BMC GASTROENTEROL, vol. 3, no. 13, 2013, pages 1 - 6
SVEDLUND ET AL., DIG. DIS. SCI., vol. 33, no. 2, 1988, pages 129 - 34
Attorney, Agent or Firm:
MARSH, David et al. (US)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: PACKAGING FOR MICROLEDS FOR CHIP TO CHIP COMMUNICATION

Next Patent: WIRELESS CHARGING TRANSFER APPARATUS AND METHODS